BR0302424A - Composição farmacêutica com biodisponibilidade ampliada adequada à adiministração oral de inibidores da protease retroviral. processo de preparação de composição farmacêutica concentrada contendo inibidor da protease retroviral - Google Patents
Composição farmacêutica com biodisponibilidade ampliada adequada à adiministração oral de inibidores da protease retroviral. processo de preparação de composição farmacêutica concentrada contendo inibidor da protease retroviralInfo
- Publication number
- BR0302424A BR0302424A BR0302424-5A BR0302424A BR0302424A BR 0302424 A BR0302424 A BR 0302424A BR 0302424 A BR0302424 A BR 0302424A BR 0302424 A BR0302424 A BR 0302424A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- retroviral protease
- preparing
- oral administration
- protease inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA COM BIODISPONIBILIDADE AMPLIADA ADEQUADA A ADMINISTRAçãO ORAL DE INIBIDORES DA PROTEASE RETROVIRAL. PROCESSO DE PREPARAçãO DE COMPOSIçãO FARMACêUTICA CONCENTRADA CONTENDO INIBIDOR DA PROTEASE RETROVIRAL". A presente invenção descreve uma composição farmacêutica com biodisponibilidade ampliada, adequada a confecção de microcápsulas para a administração terapêutica de um inibidor de protease. é descrito também um processo de preparação de composição farmacêutica com biodisponibilidade ampliada, adequado ao preparo de composições farmacêuticas concentradas de inibidores da protease retroviral.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0302424-5A BR0302424A (pt) | 2003-07-23 | 2003-07-23 | Composição farmacêutica com biodisponibilidade ampliada adequada à adiministração oral de inibidores da protease retroviral. processo de preparação de composição farmacêutica concentrada contendo inibidor da protease retroviral |
EP04737712A EP1660522A4 (en) | 2003-07-23 | 2004-07-19 | PHARMACEUTICAL COMPOSITION WITH INCREASED BIODISIBILITY APPROPRIATE FOR ADMINISTRATION OF ORAL RETROVIRAL PROTEASE INHIBITORS. PROCESS FOR PREPARING A CONCENTRATED PHARMACEUTICAL COMPOSITION COMPRISING A RETROVIRAL PROTEASE INHIBITOR |
PCT/BR2004/000118 WO2005007069A2 (en) | 2003-07-23 | 2004-07-19 | Soft gel formulations for saquinavir |
US10/565,220 US20060217320A1 (en) | 2003-07-23 | 2004-07-19 | Soft gel formulations for saquinavir |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0302424-5A BR0302424A (pt) | 2003-07-23 | 2003-07-23 | Composição farmacêutica com biodisponibilidade ampliada adequada à adiministração oral de inibidores da protease retroviral. processo de preparação de composição farmacêutica concentrada contendo inibidor da protease retroviral |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0302424A true BR0302424A (pt) | 2005-03-29 |
Family
ID=36204663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0302424-5A BR0302424A (pt) | 2003-07-23 | 2003-07-23 | Composição farmacêutica com biodisponibilidade ampliada adequada à adiministração oral de inibidores da protease retroviral. processo de preparação de composição farmacêutica concentrada contendo inibidor da protease retroviral |
Country Status (4)
Country | Link |
---|---|
US (1) | US20060217320A1 (pt) |
EP (1) | EP1660522A4 (pt) |
BR (1) | BR0302424A (pt) |
WO (1) | WO2005007069A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120035211A1 (en) * | 2009-02-17 | 2012-02-09 | Hetero Research Foundation | Novel polymorphs of saquinavir |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439437A (en) * | 1981-04-28 | 1984-03-27 | Smith Kline & French Laboratories Limited | 2-[2-Thiazolyl or 2-guanidino-4-thiazolyl methylthioethyl(or butyl)amino]-3-(hydroxy or carboxy)pyridines, compositions containing same and method of use |
ZA9710071B (en) * | 1996-11-21 | 1998-05-25 | Abbott Lab | Pharmaceutical composition. |
US6232333B1 (en) * | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
EP1039893B1 (en) * | 1997-12-10 | 2011-02-02 | Cyclosporine Therapeutics Limited | Pharmaceutical compositions containing an omega-3 fatty acid oil |
US6299906B1 (en) * | 1998-04-09 | 2001-10-09 | Hoffmann-La Roche Inc. | Process for making submicron particles |
US7141593B1 (en) * | 1999-06-04 | 2006-11-28 | Abbott Laboratories | Pharmaceutical formulations |
-
2003
- 2003-07-23 BR BR0302424-5A patent/BR0302424A/pt not_active IP Right Cessation
-
2004
- 2004-07-19 WO PCT/BR2004/000118 patent/WO2005007069A2/en active Search and Examination
- 2004-07-19 EP EP04737712A patent/EP1660522A4/en not_active Withdrawn
- 2004-07-19 US US10/565,220 patent/US20060217320A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005007069A3 (en) | 2005-09-22 |
WO2005007069A2 (en) | 2005-01-27 |
US20060217320A1 (en) | 2006-09-28 |
EP1660522A2 (en) | 2006-05-31 |
EP1660522A4 (en) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0209431A (pt) | Novos compostos de 4-anilinoquinolino-3-carboxamidas | |
BR0206955A (pt) | Ligantes de receptores de canabinóides | |
MA29550B1 (fr) | Derives de n- (pyridine-2-yl) - sulfonamide | |
AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
NO20043367L (no) | Oralt farmasoytisk preparat | |
HUP0203257A2 (hu) | Atorvastatin kalcium polimorf módosulatai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0303128A2 (hu) | O-dezmetil-venlafaxin új szukcinátsója, eljárás az előállításukra, alkalmazása és ezt tartalmazó gyógyszerkészítmény | |
CR7069A (es) | Derivados de pirazol para el tratamiento de vih | |
BR0113234A (pt) | Polimorfos de um análogo de epotilona | |
BR0315296A (pt) | Derivados do ciclohexanol espirocìclicos | |
UY27548A1 (es) | Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas | |
DE60034240D1 (de) | Drogen zur behandlung maligner tumoren | |
SE0302760D0 (sv) | New compounds | |
BR9707064A (pt) | Novos derivados 19-nor-pregneno | |
HN2002000198A (es) | Composiciones farmaceuticas de amlodipina y atorvastatina | |
BR0209845A (pt) | Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas | |
BR0212214A (pt) | Base livre de clindamicina cristalina | |
BR0107564A (pt) | Composição de gliburida | |
UY27700A1 (es) | Compuestos oxo - azabiclícos. | |
BR9916575A (pt) | Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa | |
NO20062143L (no) | Tablettformuleringer av venlafaxin med forlenget frigjoring | |
HUP0401080A2 (hu) | Új görcsoldó sószármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DOP2002000390A (es) | Sal citrato de 5,8 14-hiezatetraciclo [10.3.1.0 2,11. 0.4.9] hexadeca-2(11),3,5,8,9, pentaeno y composiciones farmaceuticas de las mismas | |
SE0102440D0 (sv) | New compound | |
BRPI0410623A (pt) | composto, processo para preparação de um composto, composição farmacêutica, e, utilização de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07F | Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette] |
Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2316 DE 26-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |